You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

Claims for Patent: 5,256,410

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,256,410

Title:	Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
Abstract:	Human squamous cell carcinoma is successfully treated by intralesional administration of recombinant human interferon alpha-2b.
Inventor(s):	Tanner; Daniel J. (Brooklyn, NY), Peets; Edwin A. (New York, NY), Smiles; Kenneth A. (Novato, CA)
Assignee:	Schering Corporation (Kenilworth, NJ)
Application Number:	07/684,964
Patent Claims:	1. A method for treating human squamous cell carcinoma comprising intralesionally administering to a human in need of such treatment a sufficient amount of a purified recombinant human alpha-2 interferon to be effective as an anti-squamous cell carcinoma agent. 2. A method of claim 1 wherein the alpha-2 interferon is recombinant human interferon alfa-2b. 3. A method of claim 1 wherein treatment is effected by administering a dosage of 0.1 to 10.times.10.sup.6 International Units of recombinant human alpha-2 interfereon by injection. 4. A method of claim 1 wherein the dosage is 1.5.times.10.sup.6 International Units. 5. A method of claim 4 wherein the dosage is administered three days a week for three weeks.

Details for Patent 5,256,410

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986	⤷ Try a Trial	2010-10-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132		⤷ Try a Trial	2010-10-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132		⤷ Try a Trial	2010-10-26
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.